BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi X, Ma R, Lu Y, Cheng Y, Fan X, Zou J, Zheng H, Li F, Piao J. iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas. Biochemical and Biophysical Research Communications 2020;527:117-23. [DOI: 10.1016/j.bbrc.2020.04.064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Qiu Z, Yu Z, Xu T, Wang L, Meng N, Jin H, Xu B. Novel Nano-Drug Delivery System for Brain Tumor Treatment. Cells 2022;11:3761. [DOI: 10.3390/cells11233761] [Reference Citation Analysis]
2 Li X, Ta W, Hua R, Song J, Lu W. A Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy. Biomedicines 2022;10:2455. [PMID: 36289715 DOI: 10.3390/biomedicines10102455] [Reference Citation Analysis]
3 Wang R, Liang Q, Zhang X, Di Z, Wang X, Di L. Tumor-derived exosomes reversing TMZ resistance by synergistic drug delivery for glioma-targeting treatment. Colloids Surf B Biointerfaces 2022;215:112505. [PMID: 35487070 DOI: 10.1016/j.colsurfb.2022.112505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liang M, Li J, Han L. Receptor-mediated cascade targeting strategies for the application to medical diagnoses and therapeutics of glioma. J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05482-8] [Reference Citation Analysis]
5 Chen J, Cao F, Cao Y, Wei S, Zhu X, Xing W. Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel. J Biomed Nanotechnol 2022;18:1075-83. [PMID: 35854459 DOI: 10.1166/jbn.2022.3278] [Reference Citation Analysis]
6 Zhong X, Di Z, Xu Y, Liang Q, Feng K, Zhang Y, Di L, Wang R. Mineral medicine: from traditional drugs to multifunctional delivery systems. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00577-9] [Reference Citation Analysis]
7 Chen X, Fan X, Zhang Y, Wei Y, Zheng H, Bao D, Xu H, Piao J, Li F, Zheng H. Cooperative coordination-mediated multi-component self-assembly of “all-in-one” nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.027] [Reference Citation Analysis]
8 Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release 2021;340:221-42. [PMID: 34757195 DOI: 10.1016/j.jconrel.2021.10.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 21.0] [Reference Citation Analysis]
9 Horák D, Turnovcová K, Plichta Z, Mareková D, Proks V, Kaiser R, Netuka D, Jendelová P. RGDS- and doxorubicin-modified poly[N-(2-hydroxypropyl)methacrylamide]-coated γ-Fe2O3 nanoparticles for treatment of glioblastoma. Colloid Polym Sci 2022;300:267-77. [DOI: 10.1007/s00396-021-04895-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhong J, Xia B, Shan S, Zheng A, Zhang S, Chen J, Liang XJ. High-quality milk exosomes as oral drug delivery system. Biomaterials 2021;277:121126. [PMID: 34544033 DOI: 10.1016/j.biomaterials.2021.121126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
11 Medeiros M, Candido MF, Valera ET, Brassesco MS. The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors? Cell Mol Life Sci 2021. [PMID: 34333711 DOI: 10.1007/s00018-021-03906-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Luiz MT, Delello Di Filippo L, Tofani LB, de Araújo JTC, Dutra JAP, Marchetti JM, Chorilli M. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. Int J Pharm 2021;604:120758. [PMID: 34090991 DOI: 10.1016/j.ijpharm.2021.120758] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Jin Z, Yi X, Yang J, Zhou M, Wu P, Yan G. Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma. Int J Nanomedicine 2021;16:3775-88. [PMID: 34113100 DOI: 10.2147/IJN.S313962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
14 Mojarad-Jabali S, Farshbaf M, Walker PR, Hemmati S, Fatahi Y, Zakeri-Milani P, Sarfraz M, Valizadeh H. An update on actively targeted liposomes in advanced drug delivery to glioma. Int J Pharm 2021;602:120645. [PMID: 33915182 DOI: 10.1016/j.ijpharm.2021.120645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
15 Timur SS, Gürsoy RN. The role of peptide-based therapeutics in oncotherapy. J Drug Target 2021;:1-15. [PMID: 33775190 DOI: 10.1080/1061186X.2021.1906884] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Xu H, Li C, Wei Y, Zheng H, Zheng H, Wang B, Piao JG, Li F. Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy. Biochem Biophys Res Commun 2021;551:14-20. [PMID: 33714754 DOI: 10.1016/j.bbrc.2021.02.138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
17 Ban J, Li S, Zhan Q, Li X, Xing H, Chen N, Long L, Hou X, Zhao J, Yuan X. PMPC Modified PAMAM Dendrimer Enhances Brain Tumor-Targeted Drug Delivery. Macromol Biosci 2021;21:e2000392. [PMID: 33506646 DOI: 10.1002/mabi.202000392] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
18 Zhu J, Zhang Y, Chen X, Zhang Y, Zhang K, Zheng H, Wei Y, Zheng H, Zhu J, Wu F, Piao JG, Zhu Z, Li F. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB. Biochem Biophys Res Commun 2021;534:902-7. [PMID: 33162028 DOI: 10.1016/j.bbrc.2020.10.076] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]